All rankings on TirzepatideReview.com are based solely on independent editorial assessment.

|

We do not accept paid advertisements, sponsored placements, or compensation to influence rankings.

| people viewing this page
Important Notice Credential Standards Specialty Examples Questions to Ask Red Flags
⚠️

We Are Not Endorsing or Vouching for Any Specific Physicians

The physicians shown below are examples of the types of specialties and credentials that are appropriate for GLP-1 prescribing. We are not endorsing, recommending, or vouching for any specific individual physician. These images represent the type of qualified medical professional — not specific named individuals. Always independently verify any provider's credentials through your state medical board before accepting a prescription.

Why Physician Credentials Matter for GLP-1 Medications

Tirzepatide and semaglutide are powerful prescription medications with real physiological effects, real side effects, and real contraindications. They are not supplements. They are not over-the-counter products. They require individualized clinical evaluation, appropriate dosing protocols, proper titration oversight, and the ability to manage complications if they arise.

The explosive growth of telehealth GLP-1 prescribing has brought enormous convenience — but also an influx of prescribers whose training and credentials vary widely. Some patients have unknowingly received prescriptions from providers with minimal relevant training, no formal medical degree, or no licensure in their state. This is a patient safety concern.

The fundamental standard is straightforward: GLP-1 medications should be prescribed and managed by physicians who hold an MD or DO degree from an accredited medical school, are licensed in the patient's state, and hold board certification in a specialty with direct relevance to metabolic medicine, obesity, internal medicine, family medicine, or endocrinology.

This page exists to educate patients on those standards. It does not constitute medical advice, and it does not evaluate or endorse any individual physician.


Credential Standards
What Qualified GLP-1 Physicians Look Like

These are the credential benchmarks patients should verify before agreeing to receive a GLP-1 prescription from any telehealth provider.

⛔ Not Acceptable — These Are Not GLP-1 Prescribers

  • Naturopathic Doctors (ND) — Naturopathic school is not medical school. NDs do not hold MD or DO degrees and do not receive the clinical training required to safely manage prescription pharmacotherapy, drug interactions, or metabolic complications. In most states, NDs cannot legally prescribe Schedule medications. This is not a qualifying credential for GLP-1 prescribing.
  • Chiropractors (DC) — Chiropractic school is not medical school. DCs hold no training in pharmacology, endocrinology, or metabolic medicine. They cannot and should not be prescribing any prescription medication, including GLP-1 receptor agonists. Full stop.
  • Occupational Medicine practitioners without relevant board certification — While occupational medicine is a legitimate specialty, it focuses on workplace injuries and exposures — not obesity pharmacotherapy or metabolic disease. Occupational medicine training does not qualify a provider to manage GLP-1 medications.
  • Health coaches or "wellness practitioners" — No licensing, no prescribing authority, no accountability. If your GLP-1 is being managed by someone without a medical license, that is a serious patient safety risk.
  • Providers without state licensure in your state — Every prescriber must be licensed in the state where the patient resides and is receiving the medication. This is a legal requirement. A provider licensed only in a different state cannot legally prescribe to you.

✓ What You Should Require — Non-Negotiable Standards

  • MD or DO degree from an accredited U.S. (or equivalent international) medical school. These are the only two credentials that represent completion of a full 4-year medical school curriculum, clinical rotations, residency training, and licensing examinations (USMLE or COMLEX). There is no substitute for this foundation when managing prescription pharmacotherapy.
  • Active medical license in your state of residence. Verify this independently using your state medical board's public license lookup tool. This takes 60 seconds and is always worth doing.
  • Board certification in a relevant specialty — specifically: Obesity Medicine (ABOM), Internal Medicine, Family Medicine, Endocrinology, or a closely related field. Board certification means the physician has passed rigorous specialty-specific examinations above and beyond their medical degree.
  • Obesity Medicine board certification (ABOM) is the gold standard for GLP-1 prescribing. Physicians certified by the American Board of Obesity Medicine have demonstrated specific, tested competence in the pharmacological and behavioral management of obesity — exactly what GLP-1 treatment requires.
  • Demonstrated clinical experience with GLP-1 medications specifically. Ask how many patients they have managed on tirzepatide or semaglutide, and what their protocol is for dose titration, side effect management, and escalation of care if needed.
  • Ongoing medical oversight throughout treatment — not just a one-time online questionnaire. A qualified physician will monitor your progress, adjust dosing based on response, and be available for questions and complications.

Must Have

  • MD or DO from accredited medical school
  • Active state license where patient resides
  • DEA registration for Schedule medications
  • Residency training completion
  • Malpractice insurance coverage

Strongly Preferred

  • Board certified by ABOM (Obesity Medicine)
  • Board certified: Internal or Family Medicine
  • Ongoing CME in metabolic/obesity medicine
  • Active GLP-1 prescribing experience
  • Established dose titration protocols

Not Acceptable

  • Naturopathic Doctor (ND) — not medical school
  • Chiropractor (DC) — not medical school
  • Out-of-state prescriber (unlicensed in your state)
  • Health coach or wellness practitioner
  • No ongoing oversight after prescription

Specialty Examples — Illustrative Only
Types of Physicians Who Commonly Work with GLP-1 Medications
Important: The physicians shown below are illustrative examples of the types of specialties and credentials that are appropriate for GLP-1 prescribing. We are not endorsing, recommending, or vouching for any specific individual physician. These images represent the type of qualified medical professional — not specific named individuals. Always independently verify any provider's credentials through your state medical board before accepting a prescription.
Physician in white coat — Family Medicine
Dr. M., MD
Family Medicine — Board Certified
MD — University of California Irvine, School of Medicine ABFM Board Certified State Licensed
Family medicine physicians receive broad clinical training across internal medicine, pediatrics, gynecology, and chronic disease management. Their scope includes metabolic conditions such as type 2 diabetes, obesity, hypertension, and dyslipidemia — making them well-positioned to prescribe and manage GLP-1 medications when they also carry relevant obesity medicine experience or certification. Family physicians with ABOM certification represent an excellent combination of primary care continuity and specialized metabolic expertise.
Physician in white coat — Emergency Medicine & Obesity Medicine
Dr. B., DO
Emergency Medicine & Obesity Medicine — Board Certified
DO — Western University of Health Sciences, College of Osteopathic Medicine ABOM Board Certified ABEM Board Certified State Licensed
Emergency medicine physicians who pursue additional board certification in obesity medicine (ABOM) represent a particularly rigorous credential combination. Emergency medicine training demands mastery of acute pharmacology, systemic physiology, and complex drug interactions — translating directly to safe GLP-1 prescribing. Dual board certification in Emergency Medicine (ABEM) and Obesity Medicine (ABOM) signals a physician who has gone above and beyond to develop specific expertise in the very medications they are prescribing. This credential combination is among the strongest available in telehealth GLP-1 care.

Why MD/DO from Medical School is the Non-Negotiable Baseline

Medical school (MD or DO) is a 4-year graduate program following a bachelor's degree. It includes two years of foundational biomedical sciences (pharmacology, physiology, pathology, biochemistry) and two years of clinical rotations across all major specialties. This is followed by a minimum 3-year residency — supervised clinical practice in a specialty — and national licensing examinations (USMLE for MD, COMLEX for DO) at multiple stages.

This training is what qualifies a physician to understand drug mechanisms, recognize contraindications, manage adverse effects, interpret labs, and escalate care when something goes wrong. There is no shortcut and no equivalent. A naturopathic program, chiropractic program, or occupational therapy program does not provide this foundation, and providers from these backgrounds are not qualified to prescribe GLP-1 receptor agonists regardless of how they market themselves online.

The bottom line: If your telehealth provider cannot confirm that the physician reviewing your case holds an MD or DO degree, is licensed in your state, and is board certified in a relevant specialty — you should find a different provider. Your safety depends on it.

Patient Empowerment
Questions to Ask Any GLP-1 Telehealth Provider

Before accepting a GLP-1 prescription from any online provider, patients should ask these questions. A qualified, legitimate provider will answer all of them clearly and willingly.

1
What is the prescribing physician's degree? MD or DO? Ask specifically for their degree, the medical school they attended, and year of graduation. Any hesitation to provide this information is a red flag.
2
Is the physician licensed in my state? Verify this independently at your state medical board website. Ask the provider which state(s) the prescribing physician is licensed in before your consultation begins.
3
What board certifications does the physician hold? Look for: ABOM (Obesity Medicine), ABIM (Internal Medicine), ABFM (Family Medicine), or ABE (Endocrinology). These are the most relevant certifying boards for GLP-1 prescribing.
4
What is the titration protocol for my medication? A knowledgeable physician will be able to explain the standard dose escalation schedule, why it exists, and what criteria they use to adjust dosing. A vague or scripted answer suggests limited clinical engagement.
5
Who do I contact if I experience side effects or a reaction? There must be a clear, accessible pathway to reach a licensed physician — not just a chatbot or an email queue — in the event of an adverse reaction.
6
Is the pharmacy dispensing my medication licensed and accredited? Look for NABP (National Association of Boards of Pharmacy) accreditation and LegitScript certification. Ask whether the compounded medication undergoes independent third-party testing for potency, sterility, and endotoxin levels.

Patient Safety
Red Flags to Watch For in GLP-1 Telehealth

⚠️ These Are Warning Signs — Proceed with Extreme Caution

  • Provider refuses to confirm the prescriber's medical degree or license number. Every licensed physician has a publicly verifiable license number. If a provider won't give you this information, something is wrong.
  • Your "prescriber" has a title of ND (Naturopath), DC (Chiropractor), NMD, or similar non-MD/DO credential. These individuals did not attend medical school and are not qualified to prescribe or manage GLP-1 medications regardless of how they position their services.
  • The consultation is entirely automated with no actual physician review. Some platforms use questionnaire-only intake with no genuine physician evaluation. GLP-1 medications require individualized clinical assessment — a checkbox form is not a medical consultation.
  • No mention of contraindications or safety screening during intake. A legitimate GLP-1 prescriber will screen for thyroid cancer history, MEN2 syndrome, pancreatitis history, and other contraindications. If intake skips this entirely, the physician is not conducting a real clinical evaluation.
  • Claims that their product is "FDA-approved" when referring to compounded tirzepatide or semaglutide. Compounded GLP-1 medications are not FDA-approved. They may be legally prescribed under patient-specific compounding rules, but a provider making FDA approval claims for compounded formulations is misleading patients.
  • No accessible physician for follow-up or adverse event management. If you cannot reach a licensed physician for follow-up care, the provider is not meeting the standard of care for prescription medication management.

Page Disclosure: This page is for patient education only. The physician images are illustrative representations of specialty types and credentials — not endorsements of specific individuals. TirzepatideReview.com does not vouch for, recommend, or verify any individual physician. Always independently verify any provider's credentials through your state medical board's public license lookup tool before accepting a prescription. This content does not constitute medical advice, diagnosis, or treatment.